1. What is Fahr disease's genetic component?
Fahr disease, also known as idiopathic basal ganglion calcification (IBGC), has a genetic component, but the specifics of inheritance and the involved genes still need clarification. Although a genetic component is associated with this disease, the exact mechanism underlying the formation of calcium deposits remains unclear. The term 'idiopathic' is used to describe a disease or condition with an unknown or unclear origin, which reflects our current understanding of Fahr disease. Bilateral basal ganglion calcification is a typical feature for diagnosing Fahr disease, but additional calcification in other areas can be difficult to distinguish from brain lesions accompanied by calcification. Further research is needed to fully understand the genetic factors contributing to Fahr disease.
read more
2. What is Fahr disease and its presentation?
Fahr disease, also known as idiopathic basal ganglion calcification, is a rare and genetically heterogeneous neurological disorder. It presents with multiple cerebral calcifications, as seen in a case where a 63-year-old woman presented with dizziness. Brain CT revealed high-intensity lesions in basal ganglia, cerebellar hemispheres, and left frontal lobe. MRI showed no prominent lesions, but multiple dark signals were detected on gradient echo MRI. The patient was diagnosed with Fahr disease after a careful radiological and clinical review, highlighting the importance of considering multiple intracranial calcifications as a warning sign for this condition.
read more
3. What is Fahr disease diagnosis based on?
Fahr disease diagnosis is based on the presence of multiple calcified lesions in various brain regions, including basal ganglia, cerebellar hemispheres, and frontal lobe. The diagnosis is made after considering the imaging findings, clinical features, and ruling out other conditions such as CCM or brain tumor. In this case, the patient's symptoms of intermittent dizziness and the absence of cognitive impairment, movement disorder, or focal neurological deficits led to the diagnosis of Fahr disease. The dense dark signals observed in the basal ganglia and mild dark signals in the cerebellar hemisphere and frontal lobe further supported the diagnosis. Additionally, the fact that calcifications could occur in other forms besides bilateral basal ganglion calcifications played a crucial role in confirming the diagnosis of Fahr disease.
read more
4. What are the genetic mutations associated with Fahr disease?
Recent genetic mutations for Fahr disease have been described in SLC2042, PDGFB, and PDG-FRB. These findings contribute to the understanding of the disease's pathophysiology and may aid in the development of future treatments. The identified genetic mutations have different pathogenic mechanisms, suggesting that Fahr disease is not a monogenic disorder. Several mechanisms of calcium or phosphate transport contribute to the end result of brain calcification. Fahr disease refers to idiopathic calcification of the basal ganglion without a secondary cause, and the clinical presentation can vary widely among patients. Diagnosis is challenging due to the rarity of the condition and the wide variety of clinical presentations. The main radiologic tool for diagnosis is a CT scan, which is more sensitive than MRI. The degree of density and symmetry of calcification may be associated with disease progression. Diagnosis of Fahr disease with MRI alone is challenging, and a combination of history, clinical presentation, and imaging findings is necessary for a definite diagnosis.
read more